The Evolving Landscape in Molecular-Driven Investigational Therapies for Advanced Endometrial Cancer, an Industry Supported Symposium at IGCS 2023
Activity Overview
Karyopharm Therapeutics welcomes gynecologic oncologists, oncologists, advanced practitioners (NP/PA/PharmD), and other clinicians who treat patients with gynecologic malignancies to register for access to the The Evolving Landscape in Molecular-Driven Investigational Therapies for Advanced Endometrial Cancer Enduring Education Materials, an Industry Supported Symposium at the IGCS 2023 Annual Global Meeting in Seoul, South Korea.
This sixty-minute virtual symposium will discuss emerging molecular-driven therapeutics in advanced endometrial cancer (EC). The overall goal is to educate on how molecular profiling is driving advancement in EC research and how the development landscape is evolving. Expert physicians will have a robust discussion to showcase the latest clinical trial data and potential impact on future treatment.
This Industry Supported Symposium was developed by Karyopharm in partnership with The GOG Foundation, Inc.
Target Audience
The target audience for this activity is community and academic gynecologic oncologists, oncologists, advanced practitioners (NP/PA/PharmD), and other providers who treat patients with gynecologic malignancies.
Learning Objectives
-
- Discuss potential impact of endometrial cancer molecular profiling and understand what select molecular markers may mean for patients.
- Understand latest clinical trial data and emerging molecular-driven approaches for advanced endometrial cancer.
- Review prospective directions for future treatment landscape.
Moderator
Dr. Bradley J. Monk
Faculty
Dr. Domenica Lorusso
Dr. Ritu Salani
Agenda & Presentation Materials
The Evolving Landscape in Molecular-Driven Investigational Therapies for Advanced Endometrial Cancer, an Industry Supported Symposium at the IGCS 2023 Annual Global Meeting
Presented on Monday, November 6, 2023.
Enduring Education Materials will be available for six months after the original presentation.
Bradley J. Monk, MD, US Cancer Associates, Phoenix, Arizona, USA
Bradley J. Monk, MD, US Cancer Associates, Phoenix, Arizona, USA
All Faculty
Bradley J. Monk, MD, US Cancer Associates, Phoenix, Arizona, USA
All Faculty
Domenica Lorusso, MD, PhD, Catholic University of Rome and Fondazione Policlinico Gemelli IRCCS, Rome, Italy
All Faculty
Ritu Salani, MD, MS, UCLA Medical Center, Los Angeles, California, USA
All Faculty
Bradley J. Monk, MD, US Cancer Associates, Phoenix, Arizona, USA
Technical Requirements
This virtual activity is best experienced using the most current browser (or one back) of Firefox, Chrome, Safari, Internet Explorer, or Microsoft Edge. For all activities featuring audio you must have a sound card and speakers.